Imstar-Dx will attend the 43rd European Congress of Cytology (ECC) held on October 3rd to 6th, as sponsor of the ECC and be part of 2 sessions on October 6th:Symposium Immunocytochemistry - from 11:00 to 13:00.Dr Françoise Soussaline, Imstar-Dx’ Presiden ...
IMSTAR-DX will attend the 44th “Assises de Pathologie” a national conference held on May 20th-21st, exclusively online. http://assisesdepathologie.fr/ The meeting is organized under the aegis of the International Academy of Pathology - French De ...
President Emmanuel Macron's speech on World Cancer Day organized by the National Cancer Institute (INCa) on February 4th confirms more than ever the need for early cancer detection.Imstar-Dx has been engaged in this struggle for more than 25 years, devel ...
IMSTAR received a Seal of Excellence from the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020, for its project CECAD: A novel Blood test by Cell imaging for Early&n ...
The new common language will be more simple and regular than the existing European languages. It will be as simple as Occidental; in fact, it will be Occidental. To an English person, it will seem like simplified English, as a skeptical Cambridge friend o ...
The convention is one of the most important events for Bio-Industries in China, hosting 10,000 attendees last year. IMSTAR will be present at “The French’s” booth organized by Health & Biotechnology Group, Beijing (site de H&B). The main topics o ...
Françoise Soussaline, IMSTAR President & CEO and Michel Soussaline General Manager, are invited to promote IMSTAR’s innovative technology for cancer diagnostic to the 9th International Capital Conference “The gateway to China-Europe busines ...
This symposium is an opportunity for Dr. Françoise Soussaline, President & CSO to present IMSTAR recent developments of the Pathfinder™ platform. Mrs. Soussaline will give a presentation entitled “Pathfinder Next Generation Imaging Platform f ...
Paris October 15, 2108: IMSTAR couples innovative technology developed at Bradford University with their fully-automated Pathfinder™ cell reader-analyser to create ‘Universal’ blood test for earlier diagnosis of cancer… 2018 10_TumorScan-IMSTAR Press ...
IMSTAR will participate to the 11th International Symposium on Minimal Residual Cancer and present recent technical development in its unique Pathfinder™ Cell Reader-Analyzer specific software module for CTC automated detection and counting wit ...
IA-based Solutions Quantitative Digital Pathology
Over 25 years of experience in Intelligent Software solutions, Imstar-Dx is a Spin-off of the CEA’s Nuclear Medicine Department, Life Sciences Division. Imstar-Dx is focused on cancer research and diagnosis since its inception.
© 2021 IMSTAR DX BUSINESS THEME.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
